Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

International Stem Cell (ISCO) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $57000.0.

  • International Stem Cell's Income towards Parent Company rose 14560.0% to $57000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$58000.0, marking a year-over-year increase of 9150.81%. This contributed to the annual value of -$213000.0 for FY2024, which is 7344.14% up from last year.
  • International Stem Cell's Income towards Parent Company amounted to $57000.0 in Q3 2025, which was up 14560.0% from $129000.0 recorded in Q2 2025.
  • International Stem Cell's 5-year Income towards Parent Company high stood at $129000.0 for Q2 2025, and its period low was -$641000.0 during Q3 2021.
  • For the 5-year period, International Stem Cell's Income towards Parent Company averaged around -$181684.2, with its median value being -$131000.0 (2023).
  • Its Income towards Parent Company has fluctuated over the past 5 years, first crashed by 885000.0% in 2023, then soared by 16368.72% in 2024.
  • Quarter analysis of 5 years shows International Stem Cell's Income towards Parent Company stood at -$364000.0 in 2021, then surged by 107.69% to $28000.0 in 2022, then crashed by 1735.71% to -$458000.0 in 2023, then soared by 102.62% to $12000.0 in 2024, then skyrocketed by 375.0% to $57000.0 in 2025.
  • Its Income towards Parent Company was $57000.0 in Q3 2025, compared to $129000.0 in Q2 2025 and -$256000.0 in Q1 2025.